Literature DB >> 20056724

Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

Walter Brand1, Marelle G Boersma, Hanneke Bik, Elisabeth F Hoek-van den Hil, Jacques Vervoort, Denis Barron, Walter Meinl, Hansruedi Glatt, Gary Williamson, Peter J van Bladeren, Ivonne M C M Rietjens.   

Abstract

Phase II metabolism by UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs) is the predominant metabolic pathway during the first-pass metabolism of hesperetin (4'-methoxy-3',5,7-trihydroxyflavanone). In the present study, we have determined the kinetics for glucuronidation and sulfonation of hesperetin by 12 individual UGT and 12 individual SULT enzymes as well as by human or rat small intestinal, colonic, and hepatic microsomal and cytosolic fractions. Results demonstrate that hesperetin is conjugated at positions 7 and 3' and that major enzyme-specific differences in kinetics and regioselectivity for the UGT and SULT catalyzed conjugations exist. UGT1A9, UGT1A1, UGT1A7, UGT1A8, and UGT1A3 are the major enzymes catalyzing hesperetin glucuronidation, the latter only producing 7-O-glucuronide, whereas UGT1A7 produced mainly 3'-O-glucuronide. Furthermore, UGT1A6 and UGT2B4 only produce hesperetin 7-O-glucuronide, whereas UGT1A1, UGT1A8, UGT1A9, UGT1A10, UGT2B7, and UGT2B15 conjugate both positions. SULT1A2 and SULT1A1 catalyze preferably and most efficiently the formation of hesperetin 3'-O-sulfate, and SULT1C4 catalyzes preferably and most efficiently the formation of hesperetin 7-O-sulfate. Based on expression levels SULT1A3 and SULT1B1 also will probably play a role in the sulfo-conjugation of hesperetin in vivo. The results help to explain discrepancies in metabolite patterns determined in tissues or systems with different expression of UGTs and SULTs, e.g., hepatic and intestinal fractions or Caco-2 cells. The incubations with rat and human tissue samples support an important role for intestinal cells during first-pass metabolism in the formation of hesperetin 3'-O-glucuronide and 7-O-glucuronide, which appear to be the major hesperetin metabolites found in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056724     DOI: 10.1124/dmd.109.031047

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Phenylephrine Pharmacokinetics and First-Pass Metabolism: What Is an Ideal Pharmacokinetic Surrogate?

Authors:  Nuggehally R Srinivas
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

2.  Sulfation of hesperetin, naringenin and apigenin by the human cytosolic sulfotransferases: a comprehensive analysis.

Authors:  Amal A El Daibani; Yuecheng Xi; Lijun Luo; Xue Mei; Chunyang Zhou; Shin Yasuda; Ming-Cheh Liu
Journal:  Nat Prod Res       Date:  2018-11-06       Impact factor: 2.861

3.  A Stability-Indicating HPLC Method for the Determination of Nitrosylcobalamin (NO-Cbl), a Novel Vitamin B12 Analog.

Authors:  Michael J Dunphy; Annette M Sysel; Joseph A Lupica; Kristie Griffith; Taylor Sherrod; Joseph A Bauer
Journal:  Chromatographia       Date:  2014-04-01       Impact factor: 2.044

Review 4.  First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.

Authors:  Baojian Wu; Kaustubh Kulkarni; Sumit Basu; Shuxing Zhang; Ming Hu
Journal:  J Pharm Sci       Date:  2011-04-11       Impact factor: 3.534

Review 5.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

6.  Expression, purification and characterization of human cytosolic sulfotransferase (SULT) 1C4.

Authors:  Amber L Guidry; Zachary E Tibbs; Melissa Runge-Morris; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2017-01-01

7.  Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2012-01-06       Impact factor: 3.534

8.  Microsomal quercetin glucuronidation in rat small intestine depends on age and segment.

Authors:  Bradley W Bolling; Michael H Court; Jeffrey B Blumberg; C-Y Oliver Chen
Journal:  Drug Metab Dispos       Date:  2011-05-04       Impact factor: 3.922

9.  Regioselective glucuronidation of flavonols by six human UGT1A isoforms.

Authors:  Baojian Wu; Beibei Xu; Ming Hu
Journal:  Pharm Res       Date:  2011-04-07       Impact factor: 4.200

10.  Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2012-07-13       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.